This Research Topic is the second volume of the “Unraveling Breast Cancer Complexity: Insights from Single-Cell Sequencing and Spatial Transcriptomics” ...

This article explores how advanced immune imaging technologies enable real-time visualization of immune responses, improving ...

This article explores how multiomics integration, imaging, and bioinformatics are advancing biomarker discovery, revealing ...

Researchers reviewed evidence linking the vaginal microbiome to pregnancy health and spontaneous preterm birth, highlighting ...

BostonGene, developer of the leading AI foundation model for tumor and the immune biology, today announced it has been honored as the Innovator of the Year at the 2025 Life Sciences Times Vanguard ...

Head and neck cancer (HNC) represents a significant global health challenge, characterized by aggressive local invasion, frequent recurrence, and poor survival rates. Beyond its physical burden, HNC ...

Now, scientists have made a significant advancement. In a breakthrough that seems closer to science fiction than surgery, scientists have created a working segment of the esophagus. This marks a major ...

After 30 months of fast-paced innovation in quantum algorithms, six research groups are hoping to hit paydirt. But there can ...

Researchers at UCLA have discovered a way to dramatically improve how electrical current enters perovskite semiconductors, an ...

One dog, one vaccine, one data point. The story of Rosie is fascinating – but it is not yet evidence that AI can beat cancer.

The future of precision medicine will depend less on choosing between genomics or real-world evidence and more on how effectively the two are integrated.

HAMBURG, DE / ACCESS Newswire / March 19, 2026 / Evotec SE (NASDAQ:EVO)(Frankfurt Prime Standard:EVT) today announced that its partner Bristol Myers Squibb (BMS) has initiated a Phase 1 clinical study ...